Hyperbaric oxygen (HBO 2 ) treatment is an interesting therapeutic modality (HBOT; hyperbaric oxygen therapy) in which the patient breathes 100% oxygen while exposed to increased atmospheric pressure. Generally, the therapeutic mechanisms for HBOT have been based on both the increased ambient pressure and the elevated partial oxygen pressure (pO 2 ). Increasing the ambient pressure leads to reduction in the volume of gas-filled spaces according to Boyle's law. This action is directly related to the treatment of pathological conditions in which gas bubbles are present in the patient's body, i.e., decompression sickness or gas embolism. However, most of the pathologies for which HBOT is used rely on an inflammatory background and have no pathophysiologic relation with gas bubbles. Thus, the mechanistic basis of HBOT in indications such as problematic wounds, traumatic injuries, necrotizing fasciitis, ischemiareperfusion processes, refractory osteomyelitis, and compromised flap and grafts depends on the elevation in pO 2 in bodily fluids and tissues [1] .
Oxygen is needed to support cellular respiration and consequently provides energy. Reduced delivery of oxygen can affect cell survival. Injury or disease decreases the body's ability to transport oxygen to tissues, increases the tissue demand for oxygen, and may extend the distance that the oxygen must travel from the capillary to reach the cell. By increasing arterial pO 2 , more oxygen can be delivered deeper into the tissues, and by increasing the ambient pressure from 1 to 2-2.5 atmospheres, typical working pressure with HBOT, oxygen dissolved in plasma increases approximately 17-fold (while breathing 100% oxygen). In theory, under these conditions sufficient oxygen can be dissolved in plasma to meet the normal requirements of the body at rest without the need for hemoglobin [2] .
In addition to its effects on cellular function, HBOT affects (modulates) the immune system, motivates phagocytosis and neutrophil activity within affected tissues, improves fibroblast activity, and stimulates angiogenesis [3] . This versatile functionality cannot be simply explained by improved tissue oxygenation. Therefore, more and more researchers have been interested in elucidating the molecular secrets of HBOT which are responsible for its therapeutic actions. Dr. Jeannie Le and Prof. Thom from the University of Pennsylvania in Philadelphia have contributed to this issue of the Journal of Experimental and Integrative Medicine (JEIM) with an outstanding review summarizing some details of the molecular actions of HBOT and emphasizing some possible new indication areas with regard to its already explained mechanisms [4] . For example, from this review we have learned that the stimulating effect on stem/progenitor cells to produce and release growth factors at the site of neovascularization is of special importance for wound healing processes. Furthermore, in ischemia-reperfusion injuries or for blocking the inflammatory cascade leading to neurological sequelae in carbon monoxide poisoning, an important mediating mechanism is the inhibition of β 2 integrin adhesion molecules. With regard to HBOT's protective effect in several shock models, the suppression of pro-inflammatory cytokines, such as IL-1, IL-6 or TNF-α, was pointed out for the possible underlying mechanism. For the benefit in necrotizing fasciitis, a limiting effect on the interaction of the filament protein vimentin with Group A Streptococci (GAS) is designated.
An interesting molecular action of HBOT, which seems conflicting at first glance, is to induce marked increases in the hypoxia-inducible factor-1α (HIF-1), a transcription factor functioning as a general regulator for genes that facilitate cellular adaptation and survival under hypoxic conditions [5] . Erythropoietin, a target molecule of HIF-1, is strongly known as a protective agent against ischemic insults of the central nervous system [4, 6] .
Another mechanistic approach to the therapeutic benefits of HBOT is the overproduction of reactive oxygen and nitrogen species [7] . The overproduction of these reactive molecules primarily can cause oxidative and nitrosative stress, consequently resulting in oxidative modifications of several constitutive biomolecules, i.e., lipid peroxidation, protein oxidation or DNA damage [8] . On the other hand, we also know that reactive molecules play a role in many physiological processes, and there is a necessity for their production in normal life [9] [10] [11] . It is now accepted that a considerable number of the therapeutic actions of HBOT depend on molecular interactions that are triggered by reactive or radical molecules [7, 12] . In their above referred review, Le & Thom address some details of such interesting molecular interactions of HBOT [4] . In addition to the mentioned mechanisms as the stimulating effect on stem/progenitor cells, inhibition of β 2 integrin adhesion molecules, suppression of proinflammatory cytokines, limiting the vimentin-GAS, increasing HIF-1 or free radical production, other actions with regard to nitric oxide, heat shock proteins, matrix metalloproteinases, Bcl-2 expression, etc. are also included in this paper.
Lipid peroxidation (LPO), the oxidative degradation of lipids, is probably the most extensively investigated free radical-induced chain reaction process [13] . Although mainly reported as harmful molecules, LPO products are known today for their responsibility in a considerable number of physiological functions [10, 11] . In their contribution to this issue of JEIM, Dr. Chen from China and Prof. Niki from Japan have gently outlined the bidirectional nature of LPO and related issues [14] . This paper, first summarizes the known deleterious effects of LPO products, but then notably explains some of the mechanisms for their physiological roles, such as operating with the ERK and/or JNK pathways.
Taken together, the two featured review articles of Le & Thom [4] and Chen & Niki [14] in the present issue of JEIM conjoin with the fact that reactive molecules exert substantial physiological roles. Particularly in regard to these free radical directed actions, more comprehensive research needs to be undertaken in order to elucidate the mechanistic background of HBOT's benefits in several pathologic conditions.
